184 research outputs found
Anti-IL5 Drugs in COVID-19 Patients: Role of Eosinophils in SARS-CoV-2-Induced Immunopathology
SARS-CoV-2 infection stimulates a complex activation of the immune system. Eosinophils belong to the host’s defense equipment against respiratory viruses. In the first phase of the infection, eosinophils contribution is probably appropriate and beneficial, as they facilitate the suppression of the viral replication. However, in severe COVID-19 patients, during the second and third phases of the disease, eosinophils may participate in a maladaptive immune response and directly contribute to immunopathology. In fact, in severe patients, the immune response is prevalently T helper 1 type, but T helper 2 is also present. Eosinophils’ expansion and activation are stimulated by Type 2 cytokines, especially IL-5. Moreover, bronchial asthma, in which eosinophils play a central role, seems not to be a major risk factor for severe COVID-19. Among possible explanations, asthmatic patients are often treated with corticosteroids, which have been demonstrated to reduce the progression to critical COVID-19 in hospitalized patients. In addition to steroids, severe asthmatic patients are currently treated with biological drugs that target Type 2 immune response. Because IL-5 is necessary for the growth, survival, and activation of eosinophils, IL-5 inhibitors, such as mepolizumab, decrease the peripheral blood count of eosinophils, but do not influence eosinophils activation in the airway. In severe COVID-19 patients, the blockade of eosinophils’ activation might contrast harmful immunity
Endocannabinoid-Like Lipid Neuromodulators in the Regulation of Dopamine Signaling: Relevance for Drug Addiction
The family of lipid neuromodulators has been rapidly growing, as the use of different
-omics techniques led to the discovery of a large number of naturally occurring
N-acylethanolamines (NAEs) and N-acyl amino acids belonging to the complex lipid
signaling system termed endocannabinoidome. These molecules exert a variety of
biological activities in the central nervous system, as they modulate physiological
processes in neurons and glial cells and are involved in the pathophysiology of
neurological and psychiatric disorders. Their effects on dopamine cells have attracted
attention, as dysfunctions of dopamine systems characterize a range of psychiatric
disorders, i.e., schizophrenia and substance use disorders (SUD). While canonical
endocannabinoids are known to regulate excitatory and inhibitory synaptic inputs
impinging on dopamine cells and modulate several dopamine-mediated behaviors,
such as reward and addiction, the effects of other lipid neuromodulators are far less
clear. Here, we review the emerging role of endocannabinoid-like neuromodulators
in dopamine signaling, with a focus on non-cannabinoid N-acylethanolamines and
their receptors. Mounting evidence suggests that these neuromodulators contribute to
modulate synaptic transmission in dopamine regions and might represent a target for
novel medications in alcohol and nicotine use disorder
Sex-specific tonic 2-arachidonoylglycerol signaling at inhibitory inputs onto dopamine neurons of Lister Hooded rats
Addiction as a psychiatric disorder involves interaction of inherited predispositions and environmental factors. Similarly to humans, laboratory animals self-administer addictive drugs, whose appetitive properties result from activation and suppression of brain reward and aversive pathways, respectively. The ventral tegmental area (VTA) where dopamine (DA) cells are located is a key component of brain reward circuitry, whereas the rostromedial tegmental nucleus (RMTg) critically regulates aversive behaviors. Reduced responses to either aversive intrinsic components of addictive drugs or to negative consequences of compulsive drug taking might contribute to vulnerability to addiction. In this regard, female Lister Hooded (LH) rats are more vulnerable than male counterparts to cannabinoid self-administration. We, therefore, took advantage of sex differences displayed by LH rats, and studied VTA DA neuronal properties to unveil functional differences. Electrophysiological properties of DA cells were examined performing either single cell extracellular recordings in anesthetized rats or whole-cell patch-clamp recordings in slices. In vivo, DA cell spontaneous activity was similar, though sex differences were observed in RMTg-induced inhibition of DA neurons. In vitro, DA cells showed similar intrinsic and synaptic properties. However, females displayed larger depolarization-induced suppression of inhibition (DSI) than male LH rats. DSI, an endocannabinoid-mediated form of short term plasticity, was mediated by 2-arachidonoylglycerol (2-AG) activating type 1-cannabinoid (CB1) receptors. We found that sex-dependent differences in DSI magnitude were not ascribed to CB1 number and/or function, but rather to a tonic 2-AG signaling. We suggest that sex specific tonic 2-AG signaling might contribute to regulate responses to aversive intrinsic properties to cannabinoids, thus resulting in faster acquisition/initiation of cannabinoid taking and, eventually, in progression to addiction
Combined α2- and D2-receptor blockade activates noradrenergic and dopaminergic neurons, but extracellular dopamine in the prefrontal cortex is determined by uptake and release from noradrenergic terminals
Experimental and clinical evidence indicates a deficit of release and function of dopamine in schizophrenia and suggests that α2-adrenoceptor antagonists rescue dopamine deficit and improve the antipsychotic efficacy of D2-receptor antagonists. In anesthetized male rats, we investigated how the blockade of α2- and D2-receptors by atipamezole and raclopride, respectively, modified the firing of noradrenergic neurons in the locus coeruleus (LC) and dopaminergic neurons in the ventral tegmental area (VTA). In freely moving rats, we studied how atipamezole and raclopride modified extracellular noradrenaline, dopamine, and DOPAC levels in the medial prefrontal cortex (mPFC) through microdialysis. When administered alone, atipamezole activated LC noradrenaline but not VTA dopamine cell firing. Combined with raclopride, atipamezole activated dopamine cell firing above the level produced by raclopride. Atipamezole increased extracellular dopamine to the same level, whether administered alone or combined with raclopride. In the presence of the noradrenaline transporter (NET) inhibitor, atipamezole combined with raclopride increased extracellular dopamine beyond the level produced by either compound administered alone. The results suggest that a) the D2-autoreceptor blockade is required for LC noradrenaline to activate VTA cell firing; b) the level of dopamine released from dopaminergic terminals is determined by NET; c) the elevation of extracellular dopamine levels in the mPFC is the resultant of dopamine uptake and release from noradrenergic terminals, independent of dopaminergic cell firing and release; and d) LC noradrenergic neurons are an important target for treatments to improve the prefrontal deficit of dopamine in neuropsychiatric pathologies
Crocodiles, sharks and turtles: the urban geo‑palaeontological heritage of Cagliari (Italy)
In this paper, we report on the first project on the promotion of urban geoheritage in Cagliari, the capital of the Autonomous Region of Sardinia (Italy). We briefly address the history of geo-palaeontological research in the city area and outline the main phases of development in the history of Cagliari’s geo-palaeontological museum. Geotourism is an efficient method of bringing geosciences to a wider audience. For this project, we compiled a geoitinerary of the main lithotypes and fossils present within the urban territory. Miocene lithotypes are the most important materials in the edification of the Cagliari’s old town, and in the past, the quarrying activity favoured the geology knowledge of the area. The presence of abandoned quarries and natural outcrops in parks, public gardens, on the nearby coastline, and also of fossils exposed in ashlars of historic buildings, made Cagliari an excellent example to valorise the geo-palaeontological heritage using geotourism. This project showcases the importance of knowledge transfer and non-technical communication methods by converting highly technical aspects into accessible and engaging information dissemination to a wide range of audience types, including non-specialised ones
Conjugated Linoleic Acid and Brain Metabolism: A Possible Anti-Neuroinflammatory Role Mediated by PPARα Activation
Fatty acids play a crucial role in the brain as specific receptor ligands and as precursors of
bioactive metabolites. Conjugated linoleic acid (CLA), a group of positional and geometric
isomers of linoleic acid (LA, 18:2 n-6) present in meat and dairy products of ruminants and
synthesized endogenously in non-ruminants and humans, has been shown to possess
different nutritional properties associated with health benefits. Its ability to bind to
peroxisome proliferator-activated receptor (PPAR)
α, a nuclear receptor key regulator of
fatty acid metabolism and inflammatory responses, partly mediates these beneficial effects.
CLA is incorporated and metabolized into brain tissue where induces the biosynthesis of
endogenous PPAR
α ligands palmitoylethanolamide (PEA) and oleoylethanolamide (OEA),
likely through a positive feedback mechanism where PPAR
α activation sustains its own
cellular effects through ligand biosynthesis. In addition to PPAR
α, PEA and OEA may as well
bind to other receptors such as TRPV1, further extending CLA own anti-neuroinflammatory
actions. Future studies are needed to investigate whether dietary CLA may exert antiinflammatory
activity, particularly in the setting of neurodegenerative diseases and
neuropsychiatric disorders with a neuroinflammatory basis
Combined α2- and D2-receptor blockade activates noradrenergic and dopaminergic neurons, but extracellular dopamine in the prefrontal cortex is determined by uptake and release from noradrenergic terminals
Experimental and clinical evidence indicates a deficit of release and function of dopamine in schizophrenia and suggests that a(2)-adrenoceptor antagonists rescue dopamine deficit and improve the antipsychotic efficacy of D-2-receptor antagonists. In anesthetized male rats, we investigated how the blockade of a(2)- and D-2-receptors by atipamezole and raclopride, respectively, modified the firing of noradrenergic neurons in the locus coeruleus (LC) and dopaminergic neurons in the ventral tegmental area (VTA). In freely moving rats, we studied how atipamezole and raclopride modified extracellular noradrenaline, dopamine, and DOPAC levels in the medial prefrontal cortex (mPFC) through microdialysis. When administered alone, atipamezole activated LC noradrenaline but not VTA dopamine cell firing. Combined with raclopride, atipamezole activated dopamine cell firing above the level produced by raclopride. Atipamezole increased extracellular dopamine to the same level, whether administered alone or combined with raclopride. In the presence of the noradrenaline transporter (NET) inhibitor, atipamezole combined with raclopride increased extracellular dopamine beyond the level produced by either compound administered alone. The results suggest that a) the D-2-autoreceptor blockade is required for LC noradrenaline to activate VTA cell firing; b) the level of dopamine released from dopaminergic terminals is determined by NET; c) the elevation of extracellular dopamine levels in the mPFC is the resultant of dopamine uptake and release from noradrenergic terminals, independent of dopaminergic cell firing and release; and d) LC noradrenergic neurons are an important target for treatments to improve the prefrontal deficit of dopamine in neuropsychiatric pathologies
Crocodiles, Sharks and Turtles: The urban geo-palaeontological heritage of Cagliari (Italy)
In this paper, we report on the first project on the promotion of urban geoheritage in Cagliari, the capital of the Autonomous Region of Sardinia (Italy). We briefly address the history of geo-palaeontological research in the city area and outline the main phases of development in the history of Cagliari’s geo-palaeontological museum. Geotourism is an efficient method of bringing geosciences to a wider audience. For this project, we compiled a geoitinerary of the main lithotypes and fossils present within the urban territory. Miocene lithotypes are the most important materials in the edification of the Cagliari’s old town, and in the past, the quarrying activity favoured the geology knowledge of the area. The presence of abandoned quarries and natural outcrops in parks, public gardens, on the nearby coastline, and also of fossils exposed in ashlars of historic buildings, made Cagliari an excellent example to valorise the geo-palaeontological heritage using geotourism. This project showcases the importance of knowledge transfer and non-technical communication methods by converting highly technical aspects into accessible and engaging information dissemination to a wide range of audience types, including non-specialised ones
Noradrenergic Source of Dopamine Assessed by Microdialysis in the Medial Prefrontal Cortex
Previous results indicate that dopamine (DA) release in the medial prefrontal cortex (mPFC) is modified by α2 adrenoceptor- but not D2 DA receptor- agonists and antagonists, suggesting that DA measured by microdialysis in the mPFC originates from noradrenergic terminals. Accordingly, noradrenergic denervation was found to prevent α2-receptor-mediated rise and fall of extracellular DA induced by atipamezole and clonidine, respectively, in the mPFC. The present study was aimed to determine whether DA released by dopaminergic terminals in the mPFC is not detected by in vivo microdialysis because is readily taken up by norepinephrine transporter (NET). Accordingly, the D2-antagonist raclopride increased the electrical activity of DA neurons in the ventral tegmental area (VTA) and enhanced extracellular DOPAC but failed to modify DA in the mPFC. However, in rats whose NET was either inactivated by nisoxetine or eliminated by noradrenergic denervation, raclopride still elevated extracellular DOPAC and activated dopaminergic activity, but also increased DA. Conversely, the D2-receptor agonist quinpirole reduced DOPAC but failed to modify DA in the mPFC in control rats. However, in rats whose NET was eliminated by noradrenergic denervation or inhibited by locally perfused nisoxetine, quinpirole maintained its ability to reduce DOPAC but acquired that of reducing DA. Moreover, raclopride and quinpirole, when locally perfused into the mPFC of rats subjected to noradrenergic denervation, were able to increase and decrease, respectively, extracellular DA levels, while being ineffective in control rats. Transient inactivation of noradrenergic neurons by clonidine infusion into the locus coeruleus, a condition where NET is preserved, was found to reduce extracellular NE and DA in the mPFC, whereas noradrenergic denervation, a condition where NET is eliminated, almost totally depleted extracellular NE but increased DA. Both transient inactivation and denervation of noradrenergic neurons were found to reduce the number of spontaneously active DA neurons and their bursting activity in the VTA. The results indicate that DA released in the mPFC by dopaminergic terminals is not detected by microdialysis unless DA clearance from extracellular space is inactivated. They support the hypothesis that noradrenergic terminals are the main source of DA measured by microdialysis in the mPFC during physiologically relevant activities
The Atypical Dopamine Transporter Inhibitor CE-158 Enhances Dopamine Neurotransmission in the Prefrontal Cortex of Male Rats: A Behavioral, Electrophysiological, and Microdialysis Study
Background: Dopamine plays a key role in several physiological functions such as motor control, learning and memory, and motivation and reward. The atypical dopamine transporter inhibitor S,S stereoisomer of 5-(((S)-((S)-(3-bromophenyl)(phenyl)methyl)sulfinyl)methyl)thiazole (CE-158) has been recently reported to promote behavioral flexibility and restore learning and memory in aged rats.Methods: Adult male rats were i.p. administered for 1 or 10 days with CE-158 at the dose of 1 or 10 mg/kg and tested for extracellular dopamine in the medial prefrontal cortex by means of intracerebral microdialysis and single unit cell recording in the same brain area. Moreover, the effects of acute and chronic CE-158 on exploratory behavior, locomotor activity, prepulse inhibition, working memory, and behavioral flexibility were also investigated.Results: CE-158 dose-dependently potentiated dopamine neurotransmission in the medial prefrontal cortex as assessed by intracerebral microdialysis. Moreover, repeated exposure to CE-158 at 1 mg/kg was sufficient to increase the number of active pyramidal neurons and their firing frequency in the same brain area. In addition, CE-158 at the dose of 10 mg/kg stimulates exploratory behavior to the same extent after acute or chronic treatment. Noteworthy, the chronic treatment at both doses did not induce any behavioral alterations suggestive of abuse potential (e.g., motor behavioral sensitization) or pro-psychotic-like effects such as disruption of sensorimotor gating or impairments in working memory and behavioral flexibility as measured by prepulse inhibition and Y maze.Conclusions: Altogether, these findings confirm CE-158 as a promising pro-cognitive agent and contribute to assessing its preclinical safety profile in a chronic administration regimen for further translational testing
- …